AstraZeneca Korea seeks to revamp domestic drug distribution channel via DSP

Published: 2003-10-14 06:57:00

Updated: 2003-10-14 06:57:00

Pharmaceutical business sources say that AstraZeneca Korea's new concept based on distribution streamline project designed to ameliorate the current domestic drug distribution channel has drawn keen attention from the industry.

DSP means a project that is intended for the simplicity and effici...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK